BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8562936)

  • 1. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B.
    Chauhan D; Uchiyama H; Akbarali Y; Urashima M; Yamamoto K; Libermann TA; Anderson KC
    Blood; 1996 Feb; 87(3):1104-12. PubMed ID: 8562936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.
    Uchiyama H; Barut BA; Mohrbacher AF; Chauhan D; Anderson KC
    Blood; 1993 Dec; 82(12):3712-20. PubMed ID: 8260708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
    Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
    Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligand triggered interleukin-6 secretion in multiple myeloma.
    Urashima M; Chauhan D; Uchiyama H; Freeman GJ; Anderson KC
    Blood; 1995 Apr; 85(7):1903-12. PubMed ID: 7535594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
    Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
    Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines.
    Kim I; Uchiyama H; Chauhan D; Anderson KC
    Br J Haematol; 1994 Jul; 87(3):483-93. PubMed ID: 7993788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: evidence for the involvement of NF-kappa B.
    Mori N; Shirakawa F; Shimizu H; Murakami S; Oda S; Yamamoto K; Eto S
    Blood; 1994 Nov; 84(9):2904-11. PubMed ID: 7949164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
    Zhang L; Chen SL; Chen WM; Liu JW
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications.
    Hideshima T; Chauhan D; Schlossman R; Richardson P; Anderson KC
    Oncogene; 2001 Jul; 20(33):4519-27. PubMed ID: 11494147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation.
    Xu G; Liu K; Anderson J; Patrene K; Lentzsch S; Roodman GD; Ouyang H
    Blood; 2012 May; 119(18):4205-14. PubMed ID: 22427205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.
    Salem K; Brown CO; Schibler J; Goel A
    Exp Hematol; 2013 Feb; 41(2):209-18. PubMed ID: 23063726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP.
    Wang LH; Yang XY; Zhang X; Farrar WL
    Blood; 2007 Dec; 110(13):4373-84. PubMed ID: 17785586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
    Galien R; Evans HF; Garcia T
    Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapies targeting the myeloma cell and its bone marrow microenvironment.
    Hideshima T; Chauhan D; Podar K; Schlossman RL; Richardson P; Anderson KC
    Semin Oncol; 2001 Dec; 28(6):607-12. PubMed ID: 11740818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells.
    Urashima M; Ogata A; Chauhan D; Hatziyanni M; Vidriales MB; Dedera DA; Schlossman RL; Anderson KC
    Blood; 1996 Mar; 87(5):1928-38. PubMed ID: 8634441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance.
    Chauhan D; Li G; Podar K; Hideshima T; Shringarpure R; Catley L; Mitsiades C; Munshi N; Tai YT; Suh N; Gribble GW; Honda T; Schlossman R; Richardson P; Sporn MB; Anderson KC
    Blood; 2004 Apr; 103(8):3158-66. PubMed ID: 15070698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
    Nguyen AN; Stebbins EG; Henson M; O'Young G; Choi SJ; Quon D; Damm D; Reddy M; Ma JY; Haghnazari E; Kapoun AM; Medicherla S; Protter A; Schreiner GF; Kurihara N; Anderson J; Roodman GD; Navas TA; Higgins LS
    Exp Cell Res; 2006 Jun; 312(10):1909-23. PubMed ID: 16600214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.